Sobha Sivaprasad Selected Research

aflibercept

2/2022	Visual Outcomes Associated With Patterns of Macular Edema Resolution in Central Retinal Vein Occlusion Treated With Anti-Vascular Endothelial Growth Factor Therapy: A Post Hoc Analysis of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) Trial.
1/2022	Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
9/2021	Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
5/2021	Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial.
1/2021	Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy.
1/2021	Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration.
1/2021	Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
1/2021	Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
1/2020	Aflibercept Reduces Retinal Hemorrhages and Intravitreal Microvascular Abnormalities But Not Venous Beading: Secondary Analysis of the CLARITY Study.
11/2019	Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sobha Sivaprasad Research Topics

Disease

58	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2022 - 08/2008
43	Macular Degeneration (Age-Related Maculopathy) 04/2022 - 09/2005
32	Macular Edema 11/2022 - 11/2008
15	Retinal Vein Occlusion 09/2022 - 11/2010
12	Type 2 Diabetes Mellitus (MODY) 06/2022 - 08/2008
9	Central Serous Chorioretinopathy 12/2021 - 11/2010
5	Vascular Diseases (Vascular Disease) 08/2020 - 11/2010
5	Choroidal Neovascularization 07/2017 - 09/2013
4	Vision Disorders (Hemeralopia) 01/2022 - 01/2015
4	Ganglion Cysts (Ganglion) 01/2022 - 01/2015
4	Glaucoma 01/2022 - 03/2014
4	Atrophy 01/2022 - 08/2010
4	Retinal Diseases 01/2021 - 03/2014
4	Diabetes Mellitus 01/2021 - 08/2016
4	Cataract (Cataracts) 01/2021 - 02/2012
4	Inflammation (Inflammations) 01/2017 - 07/2010
3	Retinal Neovascularization 10/2022 - 01/2019
3	Retinal Perforations 07/2022 - 07/2016
3	Telangiectasis (Telangiectasia) 01/2022 - 01/2017
3	Hyperglycemia 01/2021 - 09/2011
3	Cysts 01/2020 - 11/2007
3	Ischemia 01/2019 - 05/2014
3	Epilepsy (Aura) 01/2017 - 01/2016
3	Hypoxia (Hypoxemia) 01/2016 - 09/2011
2	Arteriosclerosis 06/2022 - 01/2021
2	Eye Diseases (Eye Disease) 01/2022 - 12/2017
2	Hypertension (High Blood Pressure) 12/2021 - 01/2015
2	Polypoidal Choroidal Vasculopathy 01/2021 - 12/2018
2	Mydriasis 01/2021 - 01/2020
2	Geographic Atrophy 01/2021 - 07/2017
2	Blindness (Hysterical Blindness) 01/2020 - 03/2019
2	Retinal Hemorrhage 01/2020 - 01/2019
2	Edema (Dropsy) 01/2019 - 03/2012
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019 - 11/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 02/2013
2	Cognitive Dysfunction 01/2016 - 10/2013
1	Chronic Renal Insufficiency 11/2022
1	Disease Progression 05/2022
1	Carotid-Cavernous Sinus Fistula 01/2022
1	Uveitis 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Microphthalmos 01/2022
1	Glucose Intolerance 01/2022
1	Isolated Systolic Hypertension 11/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2021
1	Angioid Streaks 03/2021
1	Dementia (Dementias) 01/2021
1	Neoplasms (Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

61	Retinaldehyde (Retinal)IBA 10/2022 - 11/2007
28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 03/2011
26	Ranibizumab (Lucentis)FDA Link 02/2022 - 08/2010
23	afliberceptIBA 02/2022 - 09/2015
9	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
9	Fluorescein (Funduscein)FDA LinkGeneric 10/2022 - 03/2011
6	Bevacizumab (Avastin)FDA Link 02/2022 - 09/2013
5	Complement Factor H (Factor H)IBA 01/2021 - 04/2007
4	N-acetyltryptophanamide (NATA)IBA 04/2022 - 01/2015
4	Retinal Pigments (Pigments, Visual)IBA 01/2022 - 08/2010
4	Eplerenone (Inspra)FDA LinkGeneric 12/2021 - 01/2019
3	Endothelial Growth FactorsIBA 12/2021 - 10/2020
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 12/2016
3	pegaptanib (Macugen)FDA Link 01/2014 - 06/2008
2	LipidsIBA 06/2022 - 01/2017
2	Mydriatics (Cycloplegics)IBA 01/2022 - 10/2019
2	SteroidsIBA 01/2022 - 01/2015
2	Macular PigmentIBA 01/2022 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 07/2017
2	Insulin (Novolin)FDA Link 12/2021 - 08/2016
2	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2020 - 01/2019
2	Mitochondrial DNA (mtDNA)IBA 01/2019 - 12/2015
2	Oxygen (Dioxygen)IBA 01/2018 - 11/2014
1	formycin diphosphate (FDP)IBA 07/2022
1	HomocysteineIBA 06/2022
1	oxidized low density lipoproteinIBA 06/2022
1	Lipoprotein(a)IBA 06/2022
1	Designed Ankyrin Repeat ProteinsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	rho-Associated KinasesIBA 01/2022
1	NeuroglobinIBA 01/2022
1	IntegrinsIBA 01/2022
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	chemotactic factor inactivatorIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	CytokinesIBA 01/2021

Therapy/Procedure

28	Therapeutics 09/2022 - 08/2010
19	Light Coagulation 04/2022 - 08/2008
13	Lasers (Laser) 01/2022 - 08/2008
8	Injections 01/2022 - 03/2012
4	Aftercare (After-Treatment) 05/2021 - 01/2018
4	Intravitreal Injections 01/2018 - 11/2008
3	Vitrectomy 11/2021 - 01/2018
3	Slit Lamp 01/2021 - 08/2008
3	Traction 01/2018 - 11/2008
3	Laser Therapy (Surgery, Laser) 06/2016 - 09/2013
2	Semiconductor Lasers 03/2012 - 11/2010
1	Glycemic Control 11/2021
1	Trabeculectomy (Trabeculoplasty) 07/2021
1	Intraocular Lenses (Intraocular Lens) 01/2021